glp-1 telehealth crackdown news FDA issued 30 warning letters to companies for false and misleading claims about compounded products. This marks the second round of enforcement action since the agency's September on misleading The FDA announced plans to

To qualify, Ro patients must have a body mass index (BMI) of 2730 or higher and at least one weight-related health condition, such as type 2 diabetes, high cholesterol or high blood pressure

Even modest weight loss (510% of body weight) in individuals who are overweight can improve overall metabolic health

This perspective is illustrated in Fig

Weight Loss Program is for chronic weight management in individuals with a BMI of 27 or greater who have at least one comorbidity, or those with a BMI of 30 or greater

Healthcare professionals must carefully weigh potential benefits against risks, ensure appropriate monitoring, and maintain realistic expectations about outcomes

Neither GSNO nor GSNO(ox) had any qualitative effect on the insulin fragments generated as assessed by HPLC (data not shown), suggesting that nitrosylation decreases the rate of hydrolysis, but not the specificity of IDE